Literature DB >> 32300037

Dramatic recovery of vision in patient with acute central retinal artery occlusion treated with local intra-arterial tissue plasminogen activator.

Edward A Margolin1, Amrit Rai2, Jeremy Goldfarb2, Kirill Zaslavsky2, Radha Kohly2, Patrick Nicholson3.   

Abstract

Central retinal artery occlusion (CRAO) is a devastating disease resulting in severe visual loss in most cases. It has no proven treatment, and a variety of management options used clinically all have dismal rate of success. We report outcome of treatment with local intra-arterial thrombolysis administered 2.75 hours after devastating visual loss from incomplete CRAO. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  eye; retina

Mesh：

Substances：

Year:  2020        PMID： 32300037      PMCID： PMC7199155          DOI： 10.1136/bcr-2020-234505

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  8 in total

1.  Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.

Authors:  Matthew Schrag; Teddy Youn; Joseph Schindler; Howard Kirshner; David Greer
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

2.  Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.

Authors:  Celia S Chen; Andrew W Lee; Bruce Campbell; Tien Lee; Mark Paine; Clare Fraser; John Grigg; Romesh Markus
Journal:  Stroke       Date:  2011-07-14       Impact factor: 7.914

3.  Tissue plasminogen activator and calcific emboli.

Authors:  Sankalp Gokhale; Sourabh Lahoti; Rafael Rojas; Louis R Caplan
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

4.  Acute retinal arterial ischemia.

Authors:  Michael Dattilo; Nancy J Newman; Valérie Biousse
Journal:  Ann Eye Sci       Date:  2018-06-06

5.  Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial.

Authors:  Martin Schumacher; Dieter Schmidt; Bernhard Jurklies; Christine Gall; Isabel Wanke; Claudia Schmoor; Herbert Maier-Lenz; Laszlo Solymosi; Hartmut Brueckmann; Aljoscha S Neubauer; Armin Wolf; Nicolas Feltgen
Journal:  Ophthalmology       Date:  2010-07       Impact factor: 12.079

6.  Central retinal artery occlusion. Retinal survival time.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Alan Kimura; Ashish Sanon
Journal:  Exp Eye Res       Date:  2004-03       Impact factor: 3.467

7.  Intra-arterial fibrinolytic therapy in central retinal artery occlusion.

Authors:  M Schumacher; D Schmidt; A K Wakhloo
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience.

Authors:  Eric M Aldrich; Andrew W Lee; Celia S Chen; Rebecca F Gottesman; Mona N Bahouth; Phillipe Gailloud; Kieran Murphy; Robert Wityk; Neil R Miller
Journal:  Stroke       Date:  2008-04-17       Impact factor: 7.914
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.